NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Genetic Research Centers (GRCs) (U01) | Apply Online

Opportunity Summary:

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH), offered this funding opportunity to renew and continue the work of the Inflammatory Bowel Disease Genetics Consortium (IBDGC). The consortium was originally launched in July 2002 to find genetic factors that increase a person s risk of inflammatory bowel disease (IBD). Since then, working alongside international genetics groups, the IBDGC helped identify more than 100 genetic susceptibility loci linked to IBD. Even with that progress, the announcement emphasizes that many risk genes remain undiscovered and, just as importantly, the field still has a limited understanding of how known risk variants actually affect disease biology and drive the underlying mechanisms of IBD.

This opportunity specifically supports Genetic Research Centers (GRCs) under a U01 cooperative agreement mechanism. A cooperative agreement means the project is not run as a completely investigator driven grant; instead, NIH expects substantial programmatic involvement and close coordination across awardees. In practical terms, the funded GRCs function as a network of collaborating sites that follow shared plans, standards, and governance to collectively advance the consortium s goals. The scientific aim is twofold: continue discovering additional IBD susceptibility variants and move beyond gene finding into integrated functional and systems biology work. The FOA highlights integrating genomics with epigenomics, transcriptomics, proteomics, metabolomics, and other omic approaches to clarify how genetic risk variants influence IBD pathophysiology. That framing signals an expectation for studies that connect genotype to measurable biological effects, potentially spanning molecular signatures, regulatory changes, protein pathways, metabolic profiles, and related mechanisms that explain disease onset, progression, and heterogeneity.

The GRCs are intended to be the operational backbone for human subject recruitment and sample based research. Each center serves as an enrollment site for IBD patients, their relatives (useful for family based genetics and inheritance analyses), and healthy controls. Centers are also expected to support laboratory based studies using biological specimens collected from these participants, which could include blood, tissue, or other clinically relevant samples depending on the consortium s agreed protocols. By structuring the program around multiple enrollment and sample processing hubs, the consortium can achieve larger, more diverse cohorts and generate standardized datasets and biospecimen resources suitable for cross site analyses and multi omic integration.

A key organizational feature is shared governance through the IBDGC Steering Committee. The program requires that the Program Director(s) and Principal Investigator(s) of each funded GRC participate as members of this committee. The Steering Committee is described as responsible for all operational decisions for the IBDGC, and those decisions are binding on consortium members. That language matters because it sets expectations that awardees will adhere to common policies on study design, data and specimen standards, quality control, publication and authorship practices, and collaborative decision making. It also reinforces that success is measured not only by individual site productivity, but by contributions to consortium wide objectives and coordinated outputs.

From an administrative and funding perspective, the opportunity is listed as Funding Opportunity Number RFA DK 11 032, titled NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Genetic Research Centers (GRCs) (U01). It falls under the NIH discretionary category and uses the cooperative agreement funding instrument. The CFDA number is 93.847 (Diabetes, Digestive, and Kidney Diseases Extramural Research). NIDDK anticipated up to 6 awards, with an estimated total funding level of 2,250,000 and an award ceiling of 250,000. There is no cost sharing or matching requirement. The FOA was posted February 9, 2012, with an application due date of April 30, 2012, and an archive date of May 31, 2012.

Eligibility was broad and included many organization types: public and private institutions of higher education, nonprofit organizations (including both 501(c)(3) and non 501(c)(3) entities), for profit organizations (including small businesses), state and local governments, tribal governments and tribal organizations, public housing authorities, independent school districts, and other entities as described in the announcement. Additional eligible groups explicitly noted include Alaska Native and Native Hawaiian Serving Institutions, Hispanic Serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith based and community based organizations, U.S. territories or possessions, regional organizations, eligible federal agencies, and non U.S. (foreign) entities. In short, the program was designed to allow a wide range of capable clinical and research organizations to participate, provided they could meet the consortium s recruitment, data generation, and collaborative requirements.

Overall, this FOA is centered on renewing a mature, productive genetics consortium and pushing it into the next phase: expanding discovery of IBD risk variation while directly connecting those variants to biological function through coordinated multi omic studies. The funded GRCs are expected to recruit participants and collect high quality biospecimens, perform or support laboratory analyses, and operate as a tightly coordinated network under Steering Committee governance, with NIH involvement typical of a U01 consortium model.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Food and Nutrition Health

Next opportunity: Limited Competition for Data Coordinating Center (DCC) for NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) (U01)

Previous opportunity: International Space Station National Lab Education Project

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA DK 11 032

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA DK 11 032) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA DK 11 032", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.